JFK Biotech
Hangzhou · Founded 2012
About JFK Biotech
JFK Biotech develops products for molecular diagnosis and rapid self-test technology. They also offer a series of products for early screening, early diagnosis, and early treatment of pulmonary nodules, lung cancer, COPD, asthma, airway inflammation, and airway infection.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2018)
- Website: http://www.jfkbio.com/
- Phone: +86 0571-86658059
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/jfk-biotech-142776 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.